NF-κB control of T cell development | Nature Immunology
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Effect of NF-κB activation on Th17 cell differentiation. NFκB... | Download Scientific Diagram
Factors regulating Th17 cells: a review
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis | Immunology
Tripterygium ingredients act on Th17. TGF-b/SMADs/RORgt,... | Download Scientific Diagram
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome | Nature Immunology
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24 - ScienceDirect
The non-canonical NF-κB pathway in immunity and inflammation | Nature Reviews Immunology
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer | HTML
Frontiers | TAK1-TABs Complex: A Central Signalosome in Inflammatory Responses | Immunology
PDF) NF-κB signaling in inflammation
T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation | PNAS
Frontiers | The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside | Immunology
Non-canonical NF-κB signaling pathway | Cell Research
A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections | The Journal of Immunology
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
Cytokine production by Th17 cells in CF Pathway Map - PrimePCR | Life Science | Bio-Rad
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
IJMS | Free Full-Text | Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases | HTML
Th17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway | Laboratory Investigation
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
Frontiers | Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs | Immunology
IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation: Cell Reports
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis | medRxiv
